194 related articles for article (PubMed ID: 33569423)
1. Clinicopathological characteristics and prognostic factors of pulmonary sarcomatoid carcinoma: a large population analysis.
Gang J; Yan Q; Xiang S; Zheng L; Zhao L
Ann Transl Med; 2021 Jan; 9(2):121. PubMed ID: 33569423
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for advanced pulmonary sarcomatoid carcinoma: a population-based propensity score matching study.
Wang F; Yu X; Han Y; Gong C; Yan D; Yang L; Li J; Liu S
BMC Pulm Med; 2023 Jul; 23(1):262. PubMed ID: 37454075
[TBL] [Abstract][Full Text] [Related]
3. Additional chemotherapy improves survival in stage II-III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis.
Cen Y; Yang C; Ren J; Gong Y; Xie C
Ann Transl Med; 2021 Jan; 9(1):24. PubMed ID: 33553317
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and prognostic factors of elderly small intestine adenocarcinoma using propensity score matching analysis: a study based on SEER database.
Liu QY; Xie L; Yang XY; Yang L; Lei XL
Int J Colorectal Dis; 2022 Nov; 37(11):2397-2407. PubMed ID: 36301375
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
[No Abstract] [Full Text] [Related]
6. Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database.
Rahouma M; Kamel M; Narula N; Nasar A; Harrison S; Lee B; Stiles B; Altorki NK; Port JL
Eur J Cardiothorac Surg; 2018 Apr; 53(4):828-834. PubMed ID: 29240878
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics, treatment and survival of pulmonary large cell neuroendocrine carcinoma: a SEER population-based study.
Cao L; Li ZW; Wang M; Zhang TT; Bao B; Liu YP
PeerJ; 2019; 7():e6539. PubMed ID: 30944773
[TBL] [Abstract][Full Text] [Related]
8. Can Elderly Patients With Pancreatic Cancer Gain Survival Advantages Through More Radical Surgeries? A SEER-Based Analysis.
Xie D; Qian B; Yang J; Peng X; Li Y; Hu T; Lu S; Chen X; Han Y
Front Oncol; 2020; 10():598048. PubMed ID: 33194764
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
10. Effects of surgery on survival of elderly patients with gallbladder cancer: A propensity score matching analysis of the SEER database.
Xu X; Wang J; Duan Q
Front Oncol; 2023; 13():1083618. PubMed ID: 36937413
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinicopathological characteristics and survival outcomes between gallbladder mucinous adenocarcinoma and gallbladder adenocarcinoma: A propensity score-matched study.
Yang WW; Fang YT; Niu YR; Sun YK
World J Gastrointest Oncol; 2023 Aug; 15(8):1436-1450. PubMed ID: 37663946
[TBL] [Abstract][Full Text] [Related]
12. Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database.
Chen M; Yang Q; Xu Z; Luo B; Li F; Yu Y; Sun J
Front Oncol; 2021; 11():630885. PubMed ID: 34136380
[TBL] [Abstract][Full Text] [Related]
13. Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma.
Liang X; Cheng Y; Yuan Z; Yan Z; Li Q; Huang Y; Feng G
Oncol Lett; 2020 Jun; 19(6):4031-4039. PubMed ID: 32382345
[TBL] [Abstract][Full Text] [Related]
14. Effect of histological subtype on the efficacy of perioperative chemotherapy in pulmonary sarcomatoid carcinoma: a retrospective study based on SEER population.
Wang T; Wang Z; Zhou J; Li Z; Liao H; Mei J; Pu Q; Liu L
Transl Lung Cancer Res; 2024 Apr; 13(4):749-762. PubMed ID: 38736497
[TBL] [Abstract][Full Text] [Related]
15. The role of radiotherapy in pulmonary large cell neuroendocrine carcinoma: propensity score matching analysis.
Cao L; Wu HF; Zhao L; Bai Y; Jiang ZL; Yang WJ; Liu SX
J Radiat Res; 2020 Jul; 61(4):594-601. PubMed ID: 32567658
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and prognostic analysis of metastatic pulmonary sarcomatoid carcinoma: a SEER analysis.
Xiao C; Yang X; Hao J; Guo C; Pu Q; Liu L
J Thorac Dis; 2021 Feb; 13(2):893-905. PubMed ID: 33717562
[TBL] [Abstract][Full Text] [Related]
17. Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study.
Zhao F; Yu X; Xu M; Ye S; Zang S; Zhong W; Ren G; Chen X; Yan S
Front Oncol; 2019; 9():1467. PubMed ID: 31998638
[No Abstract] [Full Text] [Related]
18. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study.
Liang L; Liu Z; Wang C; Xie S
Front Oncol; 2022; 12():940839. PubMed ID: 36091171
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study.
Chen Z; Liu J; Min L
BMC Pulm Med; 2022 Mar; 22(1):116. PubMed ID: 35361152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
